1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow 10 ug HDT 321: new trials by email Literature Review of 10 ug HDT 321 trials Research Report on 10 ug HDT 321
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever 10 ug HDT 321, 25ug HDT-321, 50ug HDT-321 - Vaccine, Crimean-Congo Hemorrhagic Fever | Phase 1 | Recruiting | HDT Bio | 48 | 2025-07-10 | 2025-07-28 |
Hemorrhagic Fever, Crimean (1)
HDT Bio (1)
United States (1)